First CGRP Blocker Approved for Kids’ Migraine Prevention

By News Health
3 hours Ago

(MedPage Today) — The FDA expanded the indication for fremanezumab (Ajovy) injection for episodic migraine prevention to include children and adolescents, Teva Pharmaceuticals announced.
Fremanezumab can now be used to treat kids ages 6 to 17…

Source link : https://www.medpagetoday.com/neurology/migraines/116885

Author :

Publish date : 2025-08-07 18:49:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Harvard Scientists Say Research Could Be Set Back Years After Funding Freeze

Trump Plan for Tariffs on Imported Drugs Draws Criticism on All Sides

More Evidence Linking Firefighting to Increased Cancer Mortality Risk

'A Bad Day for Science'; Bachelorette's PA School Update; Residency Scheduling 101

Molecule's tiny quantum jiggle imaged in unprecedented detail

Mass Transit and Active Transport Are a Boon to Health — and Climate